- Home
- GABC vs MNKD Comparison
GABC vs MNKD Comparison
Compare GABC & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GABC
- MNKD
- Stock Information
- Founded
- GABC 1910
- MNKD 1991
- Country
- GABC United States
- MNKD United States
- Employees
- GABC N/A
- MNKD N/A
- Industry
- GABC Major Banks
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- GABC Finance
- MNKD Health Care
- Exchange
- GABC Nasdaq
- MNKD Nasdaq
- Market Cap
- GABC 1.4B
- MNKD 1.2B
- IPO Year
- GABC N/A
- MNKD 2004
- Fundamental
- Price
- GABC $41.29
- MNKD $5.54
- Analyst Decision
- GABC Hold
- MNKD Buy
- Analyst Count
- GABC 3
- MNKD 6
- Target Price
- GABC $45.33
- MNKD $10.33
- AVG Volume (30 Days)
- GABC 106.4K
- MNKD 5.3M
- Earning Date
- GABC 10-27-2025
- MNKD 08-06-2025
- Dividend Yield
- GABC 2.78%
- MNKD N/A
- EPS Growth
- GABC N/A
- MNKD 149.32
- EPS
- GABC 2.62
- MNKD 0.11
- Revenue
- GABC $281,091,000.00
- MNKD $301,736,000.00
- Revenue This Year
- GABC $45.86
- MNKD $14.52
- Revenue Next Year
- GABC $6.11
- MNKD $12.81
- P/E Ratio
- GABC $15.93
- MNKD $50.97
- Revenue Growth
- GABC 13.87
- MNKD 21.48
- 52 Week Low
- GABC $32.75
- MNKD $3.38
- 52 Week High
- GABC $47.08
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- GABC 56.63
- MNKD 72.22
- Support Level
- GABC $40.71
- MNKD $5.22
- Resistance Level
- GABC $42.35
- MNKD $6.20
- Average True Range (ATR)
- GABC 0.77
- MNKD 0.26
- MACD
- GABC 0.05
- MNKD 0.18
- Stochastic Oscillator
- GABC 64.98
- MNKD 73.17
About GABC German American Bancorp Inc.
German American Bancorp Inc is a bank holding company. The lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.